Inovio Pharmaceuticals (INO) Q4 2024 Earnings

14NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.31
-1.17
-1.03
-0.89

Details

Expected EPS
-1.15
Actual EPS
-0.89
Surprise EPS
0.26
Surprise Percent
+22.61%

Description

Inovio Pharmaceuticals (INO) has reported earnings of -0.89 per share for Q4 2024.

0 Comments

Share your thoughts